[The cost of neurological disease].
Cost studies are an indispensable tool for the clinician to know the financial consequences of neurological diseases in the health care system and to establish the efficacy of the different therapeutic measures used in the daily practice. The financial burden of neurological diseases on health care and stroke costs is analyzed. The cost of neurological diseases, specifically stroke, depends mainly on their high incidence and related disability. In the case of stroke, the establishment of strategies aimed at decreasing hospital stay and disability on discharge is required to reduce the disease related cost. One of the main determinants for the cost of neurological diseases is disability. Therapeutic measures that are capable of reducing the patient's disability will also decrease the disease-associated cost.